Adenoma, Islet Cell: all 113 studies
Page 1 of 2. Open to participants first (30), then studies with results posted, then the rest; newest registration first within each.
- Endoscopic Ultrasound-Guided Pulsed Electric Field Ablation for the Treatment of Pancreatic NeoplasmsEnrolling by invitationNCT07619417Not applicable
- Nutrition Intervention for Pancreatic CancerRecruitingNCT07554560Not applicable
- AI-Powered Precision Decision-Making for Pancreatic DiseasesRecruitingNCT07439757
- Outcomes After Laparoscopic Versus Open PancreaticoduodenectomyRecruitingNCT07328607Not applicable
- Pancreatic Neuroendocrine Tumour - Optimal Surgical Debulking or NotRecruitingNCT07273409Not applicable
- Intermediate-Size Cohort EAP for Ersodetug in Patients With Inadequately Controlled Hypoglycemia Related to a TumorAvailableNCT07262970
- Study of RYZ401 in Subjects With Solid Tumors Expressing SSTRs.RecruitingNCT07165132Phase 1
- Patients With High-grade Pancreatic Neuroendocrine TumorsEnrolling by invitationNCT07121478Phase 2
- Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine TumorsRecruitingNCT06943755Phase 2/3
- A Phase 3 Study of Ersodetug in Patients With Tumor HyperinsulinismRecruitingNCT06881992Phase 3
- Study to Test the Combination of Fulvestrant With Lu-DOTATATE for Advanced Pancreatic Neuroendocrine TumorsRecruitingNCT06663072Phase 1
- A Clinical Study of Sorafenib Combined With Gefitinib for the Treatment of pNETRecruitingNCT06592989
- Genetic Bases of Neuroendocrine Neoplasms in Mexican PatientsRecruitingNCT06523582
- Everolimus 5 mg vs 10 mg/Daily for Patients With Neuroendocrine TumorsRecruitingNCT06472388Phase 2
- Temozolomide and Survivin Long Peptide Vaccine (SurVaxM) for the Treatment of Patients With Progressing Metastatic Neuroendocrine CarcinomasNot yet recruitingNCT06202066Phase 2
- Comparison of Kimura Versus Warshaw Technique for Laparoscopic Spleen-Preserving Distal PancreatectomyNot yet recruitingNCT06167421Not applicable
- Treatment of Advanced Endocrine Tumor With Iindividualized mRNA Neoantigen Vaccine (mRNA-0523-L001)RecruitingNCT06141369Not applicable
- Development of New Personalised 3D Preclinical Models of Pancreatic Neuroendocrine TumoursRecruitingNCT06121622
- Pancreatic Cancer Screening Through the Detection of Elastase-1 Combined With Other ExaminationsRecruitingNCT06041009
- Plasma cfDNA Fragmentomics for Early pNET Detection and Differential Diagnosis of Solid Pancreatic TumorsRecruitingNCT05847855
- Genetic Predisposition Testing Program for Pancreatic Neuroendocrine NeoplasmsRecruitingNCT05746182
- Testing the Addition of Sunitinib Malate to Lutetium Lu 177 Dotatate (Lutathera) in Pancreatic Neuroendocrine TumorsRecruitingNCT05687123Phase 1
- EUS-FNI for Nonfunctional Pancreatic Neuroendocrine TumorsRecruitingNCT05566093Not applicable
- EUS-FNI for MEN1-related Pancreatic Neuroendocrine TumorsRecruitingNCT05554744Not applicable
- Nimotuzumab in EGFR Highly Expressed Pancreatic Neuroendocrine NeoplasmsNot yet recruitingNCT05316480Phase 2
- Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine TumorsRecruitingNCT05040360Phase 2
- Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)RecruitingNCT04924075Phase 2
- Pancreatic Radiofrequency Under High Echo-endoscopy in the Management of Pancreatic Neuroendocrine TumorsRecruitingNCT04520932Not applicable
- Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid TumorsRecruitingNCT04119024Phase 1
- Collecting Medical Information and Tissue Samples From Patients With Pancreatic Cancer or Other Pancreatic DisordersRecruitingNCT00830557
- Trial of Nab-sirolimus in Patients With Well-differentiated Neuroendocrine Tumors (NETs) of the Gastrointestinal Tract, Lung, or Pancreas Who Have Not Received Prior Treatment With mTOR InhibitorsCompletedNCT05997056Phase 2Results posted
- Oral Cryotherapy Plus Acupressure and Acupuncture Versus Oral Cryotherapy for Decreasing Chemotherapy-Induced Peripheral Neuropathy From Oxaliplatin-Based Chemotherapy in Patients With Gastrointestinal CancerCompletedNCT04505553Phase 2Results posted
- Testing Cabozantinib in Patients With Advanced Pancreatic Neuroendocrine and Carcinoid TumorsActive, not recruitingNCT03375320Phase 3Results posted
- Phase II Study of Ibrutinib in Advanced Carcinoid and Pancreatic Neuroendocrine TumorsCompletedNCT02575300Phase 2Results posted
- An Analysis of Presentation and Outcome Following Treatment of Pancreatic Endocrine NeoplasmsCompletedNCT02400996Results posted
- OPALINE : A Study Of Morbidity And Mortality At 2 YearsCompletedNCT02264665Results posted
- Sapanisertib and Ziv-Aflibercept in Treating Patients With Recurrent Solid Tumors That Are Metastatic or Cannot Be Removed by SurgeryCompletedNCT02159989Phase 1Results posted
- Temozolomide With or Without Capecitabine in Treating Patients With Advanced Pancreatic Neuroendocrine TumorsCompletedNCT01824875Phase 2Results posted
- Cabozantinib in Advanced Pancreatic Neuroendocrine and Carcinoid TumorsCompletedNCT01466036Phase 2Results posted
- 68Ga-DOTATATE PET Scan in Neuroendocrine CancerCompletedNCT01396382Phase 2Results posted
- Efficacy of Everolimus Alone or in Combination With Pasireotide LAR in Advanced PNETTerminatedNCT01374451Phase 2Results posted
- AMG 479 in Advanced Carcinoid and Pancreatic Neuroendocrine TumorsCompletedNCT01024387Phase 2Results posted
- Doxorubicin Beads in Treating Patients With Unresectable Liver Metastases From Neuroendocrine TumorsTerminatedNCT00730483Not applicableResults posted
- RAD001 and Temozolomide in Patients With Advanced Pancreatic Neuroendocrine TumorsCompletedNCT00576680Phase 1/2Results posted
- Phase II Study of Sunitinib Malate Following Hepatic Artery EmbolizationCompletedNCT00434109Phase 2Results posted
- A Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study.CompletedNCT00428220Not applicableResults posted
- AMG 706 and Octreotide in Treating Patients With Low-Grade Neuroendocrine TumorsCompletedNCT00427349Phase 2Results posted
- Combination Chemotherapy and Bevacizumab in Treating Patients With Advanced Neuroendocrine TumorsTerminatedNCT00227617Phase 2/3Results posted
- Optimizing Risk Assessment Through cfDNA in Pancreatic Neuroendocrine Tumors for Clinical EvaluationActive, not recruitingNCT07817225
- Pancreatic Fistula After Minimally Invasive EnucleationCompletedNCT06557408
- ATRX/DAXX in EUS-FNB Specimens of Pan-NETsActive, not recruitingNCT06406387
- A Study of Surufatinib as Adjuvant Therapy for Pancreatic Neuroendocrine TumorsTerminatedNCT06158516Phase 2
- A Safety Study of 212Pb-VMT-alpha-NET in Patients With Neuroendocrine TumorsActive, not recruitingNCT06148636Early Phase 1
- Minimally Invasive Pancreatic Enucleation With Main Pancreatic Duct Exposure, Repair or ReconstructionCompletedNCT06024343Not applicable
- Multicenter Trial of ESK981 in Patients With Select Solid TumorsActive, not recruitingNCT05988918Phase 2
- A Bioequivalence Study of Sunitinib Malate Capsules.CompletedNCT05800106Phase 1
- Preoperative PRRT Versus Surgical Cytoreduction in Metastatic Pancreatic Neuroendocrine Tumors to the LiverWithdrawnNCT05610826Phase 1/2
- Neoadjuvant PRRT With Y-90-DOTATOC in pNETTerminatedNCT05568017Phase 2
- Study of RYZ101 Compared With SOC in Pts w Inoperable SSTR+ Well-differentiated GEP-NET That Has Progressed Following 177Lu-SSA TherapyActive, not recruitingNCT05477576Phase 3
- Artificial Intelligence in EUS for Diagnosing Pancreatic Solid LesionsCompletedNCT05476978
- 68Ga-DOTATOC Radio-Guided Surgery With β-Probe in GEP-NETActive, not recruitingNCT05448157
- Comparing Capecitabine and Temozolomide in Combination to Lutetium Lu 177 Dotatate in Patients With Advanced Pancreatic Neuroendocrine Tumors, the ComPareNET TrialActive, not recruitingNCT05247905Phase 2
- A Study Evaluating the Safety and Efficacy of ENV-101 (Taladegib) in Patients With Advanced Solid Tumors Harboring PTCH1 Loss of Function MutationsCompletedNCT05199584Phase 2
- Study on Microflora Characteristics of Pancreatic Solid Lesions Via Endoscopic Ultrasound-guided Fine Needle Aspiration/BiopsyCompletedNCT05171517
- Precision Radiotherapy Using MR-linac for Pancreatic Neuroendocrine Tumours in MEN1 PatientsActive, not recruitingNCT05037461Not applicable
- Related Studies of Imaging Features and Prognosis Between Pancreatic Neuroendocrine Tumors and Pancreatic CancerCompletedNCT04977596
- Ki67 Proliferation Index of Pancreatic Neuroendocrine NeoplasiaCompletedNCT04753229
- Study of Pancreatic Neuroendocrine Tumors and Carcinomas in Alsace RegionStatus unknownNCT04134832
- CT Radiomic Features of Pancreatic Neuroendocrine NeoplasmsCompletedNCT03967951
- Lanreotide 120mg Effectiveness in Subjects With Pancreatic Neuroendocrine Tumours (PanNET) in Routine Clinical Practice.TerminatedNCT03947762
- Abemaciclib in Treating Patients With Advanced, Refractory, and Unresectable Digestive System Neuroendocrine TumorsActive, not recruitingNCT03891784Phase 2
- Diagnosis of PCL With EUS-FNA and Cross-sectional Imaging - A Report of AccuracyStatus unknownNCT03884179
- Survivin Long Peptide Vaccine in Treating Patients With Metastatic Neuroendocrine TumorsCompletedNCT03879694Phase 1
- Biomarker Study of Pancreatic Neuroendocrine TumoursStatus unknownNCT03741517
- Study of CVM-1118 for Patients With Advanced Neuroendocrine TumorsActive, not recruitingNCT03600233Phase 2
- Evaluation of Safety and Feasibility of EUS-guided RFA for Solid Pancreatic NeoplasmsStatus unknownNCT03435770Not applicable
- Safety and Efficacy of an Ablation Catheter for the Treatment of Pancreatic Premalignant Cyctic Lesions.Status unknownNCT03417843Not applicable
- A Study of Tegafur Combined With Temozolomide Versus Tegafur Combined With Temozolomide and Thalidomide in Subjects With Advanced Pancreatic Neuroendocrine TumorStatus unknownNCT03204019Phase 2
- Laser Tissue Welding - Distal Pancreatectomy Sealing StudyCompletedNCT03147768Phase 1
- Atezolizumab and Bevacizumab in Treating Patients With Rare Solid TumorsActive, not recruitingNCT03074513Phase 2
- Overall and Disease Specific Survival in Patients With Confirmed MEN1 With or Without PNET (Pancreatic Neuroendocrine Tumors)Active, not recruitingNCT03043508
- Everolimus TDM to Predict Long Term ToxicityStatus unknownNCT03033186
- Nonfunctioning Small (≤2 cm) Neuroendocrine Pancreatic IncidentalomaActive, not recruitingNCT03022188
- Clinical Effectiveness of Serum Chromogranin A Levels on Diagnostic of Pancreatic Neuroendocrine TumorsStatus unknownNCT02759718Phase 4
- Pancreatic Neuroendocrine Tumor：Factor of Surgery Influencing SurvivalStatus unknownNCT02624154
- Recombinant Anti-tumor and Anti-virus Protein for Injection to Treat Advanced Neuroendocrine TumorsStatus unknownNCT02455596Phase 2
- Procaspase Activating Compound-1 (PAC-1) in the Treatment of Advanced Malignancies - Component 1CompletedNCT02355535Phase 1
- Activity and Safety of Everolimus+Octreotide LAR+Metformin in Advanced Pancreatic Well-differentiated NETsStatus unknownNCT02294006Phase 2
- A Study of BBI608 in Combination With Standard Chemotherapies in Adult Patients With Pancreatic CancerCompletedNCT02231723Phase 1
- 68Ga-DOTATATE PET Scan Imaging in Patients With Neuroendocrine TumorsStatus unknownNCT02038738Phase 1/2
- 68Ga DOTA-TATE PET/CT in Somatostatin Receptor Positive TumorsNo longer availableNCT01980732
- Chemotherapy Plus Endostatin in Advanced Pancreatic Neuroendocrine TumorCompletedNCT01845675Phase 2
- Clinical Registry of nCLE in Masses and Cystic Tumors of the Pancreas, Lymph Nodes, Submucosal Lesions of the GI TractCompletedNCT01770405
- Clinical Evaluation Of Needle-based Confocal Laser Endomicroscopy in The Lymph Nodes Along With Masses and Cystic Tumors of the PancreasStatus unknownNCT01563133Not applicable
- Biomarkers for Angiogenesis in Renal Cell Carcinoma and Neuro-endocrine Tumours.CompletedNCT01398306
- Predictive Biomarkers of Response to Sunitinib in the Treatment of Poorly-differentiated NEURO-Endocrine TumorsTerminatedNCT01215578Phase 2
- Visualizing Vascular Endothelial Growth Factor (VEGF) Producing Lesions in Von Hippel-Lindau DiseaseCompletedNCT00970970
- Sorafenib in Combination With RAD001 in Patients With Advanced Neuroendocrine TumorsCompletedNCT00942682Phase 1
- Pasireotide in Combination With RAD001 in Patients With Advanced Neuroendocrine TumorsCompletedNCT00804336Phase 1
- Pancreatic Stent to Prevent Leak After Distal PancreatectomyWithdrawnNCT00671463Not applicable